Uncategorized
Treatment arms for CRVO yield no difference in visual acuity results
BOSTON — Dexamethasone implant, ranibizumab injections or a combination of the two each yielded no statistically significant difference in visual acuity or central retinal thickness changes in treatment of central retinal vein occlusion, according to a speaker here.“The two approaches that we have currently for treatment [of CRVO] include the dexamethasone implant and the anti-VEGF agents,” Victor H. Gonzalez, MD, said at the American Society of Retina Specialists meeting, where he gave an interim analysis of the ORION study. “Because the etiology of CRVO macular edema finds its basis in (Read more...)